Nagoya, Japan

Eiichi Kato

This inventor holds 1 USPTO granted patent. Top assignee: Kabushiki Kaisha Vitamin Kenkyusho. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eiichi Kato. Retrieved from https://idiyas.com/inventor/eiichi-kato-31vnkh3l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eiichi Kato: Innovator in Androgen Receptor Research

Introduction

Eiichi Kato is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of androgen receptor research. His innovative work has led to the development of a unique agent that has potential applications in medical treatments.

Latest Patents

Eiichi Kato holds a patent for an agent that inhibits the binding of 5.alpha.-dihydrotestosterone with the androgen receptor. This agent comprises at least one extract from herbs or one of specific xanthone compounds. The process for obtaining this agent is also detailed in his patent, showcasing his expertise in the field.

Career Highlights

Kato is associated with Kabushiki Kaisha Vitamin Kenkyusho, where he continues to explore advancements in health and wellness through innovative research. His work has garnered attention for its potential impact on treatments related to hormonal imbalances.

Collaborations

Eiichi Kato has collaborated with notable colleagues, including Masayasu Kurono and Hidehumi Yamakawa. These partnerships have contributed to the advancement of research in their respective fields.

Conclusion

Eiichi Kato's contributions to the field of biochemistry and his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in androgen receptor studies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…